A proposed index of myocardial staining for vein of Marshall ethanol infusion: an Italian single-center experience.
Catheter ablation
Ethanol infusion
Mitral isthmus
Persistent atrial fibrillation
Staining
Vein of Marshall
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
received:
15
10
2023
accepted:
27
12
2023
medline:
11
1
2024
pubmed:
11
1
2024
entrez:
11
1
2024
Statut:
aheadofprint
Résumé
Mitral isthmus (MI) conduction block is a fundamental step in anatomical approach treatment for persistent atrial fibrillation (PeAF). However, MI block is hardly achievable with endocardial ablation only. Retrograde ethanol infusion (EI) into the vein of Marshall (VOM) facilitates MI block. Fluorographic myocardial staining (MS) during VOM-EI could be helpful in predicting procedural alcoholization outcome even if its role is qualitatively assessed in the routine. The aim was to quantitatively assess MS during VOM-EI and to evaluate its association with MI block achievement. Consecutive patients undergoing catheter ablation for PeAF at Fondazione Toscana Gabriele Monasterio (Pisa, Italy) from February 2022 to May 2023 were considered. Patients with identifiable VOM were included. A proposed index of MS (MSI) was retrospectively calculated in each included patient. Correlation of MSI with low-voltage zones (LVZ) extension after VOM-EI and its association with MI block achievement were assessed. In total, 42 patients out of 49 (85.8%) had an identifiable VOM. MI block was successfully achieved in 35 patients out of 42 (83.3%). MSI was significantly associated with the occurrence of MI block (OR 1.24 (1.03-1.48); p = 0.022). A higher MSI resulted in reduced ablation time (p = 0.014) and reduced radiofrequency applications (p = 0.002) to obtain MI block. MSI was also associated with MI block obtained by endocardial ablation only (OR 1.07 (1.02-1.13); p = 0.002). MSI was highly correlated with newly formed LVZ extension (r = 0.776; p = 0.001). In our study cohort, optimal MSI predicts MI block and facilitates its achievement with endocardial ablation only.
Sections du résumé
BACKGROUND
BACKGROUND
Mitral isthmus (MI) conduction block is a fundamental step in anatomical approach treatment for persistent atrial fibrillation (PeAF). However, MI block is hardly achievable with endocardial ablation only. Retrograde ethanol infusion (EI) into the vein of Marshall (VOM) facilitates MI block. Fluorographic myocardial staining (MS) during VOM-EI could be helpful in predicting procedural alcoholization outcome even if its role is qualitatively assessed in the routine. The aim was to quantitatively assess MS during VOM-EI and to evaluate its association with MI block achievement.
METHODS
METHODS
Consecutive patients undergoing catheter ablation for PeAF at Fondazione Toscana Gabriele Monasterio (Pisa, Italy) from February 2022 to May 2023 were considered. Patients with identifiable VOM were included. A proposed index of MS (MSI) was retrospectively calculated in each included patient. Correlation of MSI with low-voltage zones (LVZ) extension after VOM-EI and its association with MI block achievement were assessed.
RESULTS
RESULTS
In total, 42 patients out of 49 (85.8%) had an identifiable VOM. MI block was successfully achieved in 35 patients out of 42 (83.3%). MSI was significantly associated with the occurrence of MI block (OR 1.24 (1.03-1.48); p = 0.022). A higher MSI resulted in reduced ablation time (p = 0.014) and reduced radiofrequency applications (p = 0.002) to obtain MI block. MSI was also associated with MI block obtained by endocardial ablation only (OR 1.07 (1.02-1.13); p = 0.002). MSI was highly correlated with newly formed LVZ extension (r = 0.776; p = 0.001).
CONCLUSIONS
CONCLUSIONS
In our study cohort, optimal MSI predicts MI block and facilitates its achievement with endocardial ablation only.
Identifiants
pubmed: 38206450
doi: 10.1007/s10840-023-01732-4
pii: 10.1007/s10840-023-01732-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Voskoboinik A, Moskovitch JT, Harel N, Sanders P, Kistler PM, Kalman JM. Revisiting pulmonary vein isolation alone for persistent atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2017;14(5):661–7.
doi: 10.1016/j.hrthm.2017.01.003
pubmed: 28434446
Dixit S, Marchlinski FE, Lin D, Callans DJ, Bala R, Riley MP, et al. Randomized ablation strategies for the treatment of. Circ Arrhythm Electrophysiol. 2012;5:287–94.
doi: 10.1161/CIRCEP.111.966226
pubmed: 22139886
Verma A, Jian C, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–22.
Jaïs P, Hocini M, Hsu L-F, Sanders P, Scavee C, Weerasooriya R, et al. Technique and results of linear ablation at the mitral isthmus. Circulation. 2004;110(19):2996–3002.
doi: 10.1161/01.CIR.0000146917.75041.58
pubmed: 15520313
Pambrun T, Derval N, Duchateau J, Denis A, Chauvel R, Tixier R, et al. Epicardial course of the musculature related to the great cardiac vein: anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion. Heart Rhythm. 2021;18(11):1951–8.
Kim DT, Lai AC, Hwang C, Fan LT, Karagueuzian HS, Chen PS, et al. The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol. 2000;36(4):1324–7.
doi: 10.1016/S0735-1097(00)00819-6
pubmed: 11028490
Vlachos K, Denis A, Takigawa M, Kitamura T, Martin CA, Frontera A, et al. The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation. Heart Rhythm. 2019;16(9):1341–7.
doi: 10.1016/j.hrthm.2019.05.019
pubmed: 31125669
Thompson N, Kitamura T, Martin R, Derval N, Denis A, Jaïs P. Demonstration of persistent conduction across the mitral isthmus via the vein of Marshall with high-density activation mapping. Circ Arrhythm Electrophysiol. 2017;10(7):e005152.
Hayashi T, Fukamizu S, Mitsuhashi T, Kitamura T, Aoyama Y, Hojo R, et al. Peri-mitral atrial tachycardia using the Marshall bundle epicardial connections. JACC Clin Electrophysiol. 2016;2(1):27–35.
doi: 10.1016/j.jacep.2015.08.011
pubmed: 29766850
Ulphani JS, Arora R, Cain JH, Villuendas R, Shen S, Inderyas F, et al. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Hear Circ Physiol. 2007;293:1629–35.
doi: 10.1152/ajpheart.00139.2007
Kamanu S, Tan AY, Peter CT, Hwang C, Chen P. Vein of Marshall activity during sustained atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17:839–46 (17).
doi: 10.1111/j.1540-8167.2006.00516.x
pubmed: 16903962
Nakashima T, Pambrun T, Vlachos K, Goujeau C, André C, Krisai P, et al. Impact of vein of Marshall ethanol infusion on mitral isthmus block: efficacy and durability. Circ Arrhythm Electrophysiol. 2020;13(12):e008884.
doi: 10.1161/CIRCEP.120.008884
pubmed: 33197321
Báez-escudero JL, Morales PF, Dave AS, Sasaridis CM, Kim Y, Okishige K, et al. Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablation. Heart Rhythm. 2012;9(8):1207–15.
doi: 10.1016/j.hrthm.2012.03.008
pubmed: 22406143
pmcid: 3419362
Takigawa M, Vlachos K, Martin CA, Bourier F, Denis A, Kitamura T, et al. Acute and mid-term outcome of ethanol infusion of vein of Marshall for the treatment of perimitral flutter. Europace. 2020;22(8):1252–60.
doi: 10.1093/europace/euaa137
pubmed: 32594180
Valderrábano M, Peterson LE, Swarup V, Schurmann PA, Makkar A, Doshi RN, et al. Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation The VENUS Randomized Clinical Trial. JAMA. 2020;324(16):1620–8.
doi: 10.1001/jama.2020.16195
pubmed: 33107945
Valderrabano M, Chen HR, Sidhu J, Rao L, Ling Y, Khoury DS. Retrograde ethanol infusion in the vein of Marshall: regional left atrial ablation, vagal denervation, and feasibility in humans. Circ Arrhythmia Electrophysiol. 2009;2:50–6.
doi: 10.1161/CIRCEP.108.818427
Dave A, Baez-Escudeo J, Sasaridis C, Hong TE, Rami T, Valderrabano M. Role of the vein of Marshall in atrial fibrillation recurrences after catheter ablation: therapeutic effect of ethanol infusion. J Cardiovasc Electrophysiol. 2012Jun;23(6):583–91.
doi: 10.1111/j.1540-8167.2011.02268.x
pubmed: 22429895
Báez-escudero JL, Keida T, Dave AS. Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium. J Am Coll Cardiol. 2014;63(18):1892–901.
Derval N, Duchateau J, Denis A, Ramirez FD, Mahida S, André C, et al. Marshall bundle elimination, pulmonary vein isolation, and line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): prospective, single-center study. Heart Rhythm. 2021;18(4):529–37.
doi: 10.1016/j.hrthm.2020.12.023
pubmed: 33383226
Takagi T, Pambrun T, Nakashima T, Vlachos K, André C, Krisai P, et al. Significance of manifest localized staining during ethanol infusion into the vein of Marshall. Heart Rhythm. 2021;18:1057–63.
doi: 10.1016/j.hrthm.2021.03.023
pubmed: 33741483
Saglietto A, Ballatore A, Xhakupi H, Rubat Baleuri F, Magnano M, Gaita F, et al. Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation. Europace. 2022;24(12):1899–908.
doi: 10.1093/europace/euac098
pubmed: 35917218
Kato K, Tanaka A, Morimoto S-I, Hasegawa S, Ishiguro N, Kametani R, et al. Potential complications in patients undergoing an ethanol injection into the vein of Marshall. J Cardiovasc Electrophysiol. 2019;30(12):2743–50.
doi: 10.1111/jce.14221
pubmed: 31596017
pmcid: 6916342
Al-Kaisey AM, Kalman JM. Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good. Eur Heart J. 2023;44(9):777–9.
doi: 10.1093/eurheartj/ehac736
pubmed: 36582019
Leyton-Mange JS, Tandon K, Sze EY, Carpenter CM, Sesselberg HW. The Maine vein of Marshall ethanol experience: learning curve and safety. J Interv Card Electrophysiol. 2023;66(3):661–71.
pubmed: 36181632
Kamakura T, Derval N, Duchateau J, Denis A, Nakashima T, Takagi T, et al. Vein of Marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients. Circ Arrhythm Electrophysiol. 2021;14(8):e010001.
doi: 10.1161/CIRCEP.121.010001
pubmed: 34280029
pmcid: 8376276